KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Exchange Rate Effect (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 14 years of Exchange Rate Effect data on record, last reported at $33000.0 in Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 101.44% year-over-year to $33000.0; the TTM value through Dec 2025 reached $6.6 million, up 491.34%, while the annual FY2025 figure was $6.6 million, 491.34% up from the prior year.
  • Exchange Rate Effect reached $33000.0 in Q4 2025 per JAZZ's latest filing, down from $203000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $4.9 million in Q4 2022 and bottomed at -$5.4 million in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$170600.0, with a median of -$304000.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: crashed 2332.35% in 2024, then soared 709.22% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$1.4 million in 2021, then soared by 456.06% to $4.9 million in 2022, then plummeted by 63.75% to $1.8 million in 2023, then plummeted by 227.95% to -$2.3 million in 2024, then surged by 101.44% to $33000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Exchange Rate Effect were $33000.0 in Q4 2025, $203000.0 in Q3 2025, and $4.6 million in Q2 2025.